A Comparative Study of Endoscopic Submucosal Dissection and Photodynamic Therapy for Early Esophageal Cancer
A Phase III, Randomized, Controlled Study of Endoscopic Submucosal Dissection Versus Photodynamic Therapy for Early Esophageal Cancer
Sponsor: The First Affiliated Hospital of Henan University of Science and Technology
A NA clinical study on Esophageal Carcinoma in Situ AJCC V7, this trial is ongoing. The trial is conducted by The First Affiliated Hospital of Henan University of Science and Technology and has accumulated 4 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
4 versions recorded-
Feb 2025 — Present [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Feb 2022 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The First Affiliated Hospital of Henan University of Science and Technology
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.